This document provides information about the medication Montelukast (Singulair) including its classification, dose, route of administration, time/frequency, peak onset and duration. It notes the patient is getting this medication for asthma. The mechanism of action is described as antagonizing leukotrienes which mediate airway edema, smooth muscle constriction and altered cellular activity, decreasing inflammation. Nursing implications include potential contraindications, warnings, interactions and common side effects. Pre-administration assessments and post-administration evaluations are outlined.
This document provides information about the medication Montelukast (Singulair) including its classification, dose, route of administration, time/frequency, peak onset and duration. It notes the patient is getting this medication for asthma. The mechanism of action is described as antagonizing leukotrienes which mediate airway edema, smooth muscle constriction and altered cellular activity, decreasing inflammation. Nursing implications include potential contraindications, warnings, interactions and common side effects. Pre-administration assessments and post-administration evaluations are outlined.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
This document provides information about the medication Montelukast (Singulair) including its classification, dose, route of administration, time/frequency, peak onset and duration. It notes the patient is getting this medication for asthma. The mechanism of action is described as antagonizing leukotrienes which mediate airway edema, smooth muscle constriction and altered cellular activity, decreasing inflammation. Nursing implications include potential contraindications, warnings, interactions and common side effects. Pre-administration assessments and post-administration evaluations are outlined.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
NURS 1566 Clinical Form 3: Clinical Medications Worksheets
(You will need to make additional copies of these forms)
Generic Name Trade Name Classification Dose Route Time/frequency
Montelukast Singulair Pharmacologic: 10 mg Po Q morning leukotriene antagonists Peak Onset Duration Normal dosage range 3-4 hr within 24 hr 24 hr 10 mg once daily
Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions for asthma N/A
Mechanism of action and indications Nursing Implications (what to focus on)
(Why med ordered) Contraindications/warnings/interactions Action: Antagonizes the effects of leukotrienes, which mediate the Contraindicated if there is a hypersensitivity. Use cautiously in Acute following: Airway edema, Smooth muscle constriction Altered attacks of asthma, Hepatic impairment (may need lower doses), cellular activity; Result is decreased inflammatory process. Indicated Reduction of corticosteroid therapy (may increase the risk of eosinophilic for prevention and chronic treatment of asthma. Indicated for conditions). Drugs which induce the CYP450 enzyme system prevention and chronic treatment of asthma. (phenobarbital and rifampin ) may decrease the effects of monteleukast Common side effects CNS: fatigue, headache, weakness, EENT: otitis (children), sinusitis (children), Resp: cough, rhinorrhea, GI: abdominal pain, diarrhea (children), dyspepsia, nausea (children), increased liver enzymes, Derm: rash, Misc: EOSINOPHILIC CONDITIONS (INCLUDING CHURG-STRAUSS SYNDROME), fever Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine medicines (ask patient specifically) May cause ↑ AST and ALT concentrations none Be sure to teach the patient the following about this medication take medication daily in the evening, even if not experiencing symptoms of asthma. Do not double doses. Do not discontinue therapy without consulting health care professional. montelukast is not used to treat acute asthma attacks, but may be continued during an acute exacerbation. Patient should carry rapid-acting therapy for bronchospasm at all times. Advise patient to notify health care professional if more than the maximum number of short-acting bronchodilator treatments prescribed for a 24-hr period are needed Nursing Process- Assessment Assessment Evaluation (Pre-administration assessment) Why would you hold or not give this Check after giving Lung sounds, respiratory function, and allergy med? In case of allergy symptoms. In case of allergy